1 unknown. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Unknown 1 |
Follow EGFR-TKI: new trials by email Literature Review of EGFR-TKI trials Research Report on EGFR-TKI
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Apatinib Combined With EGFR-TKI for Advanced Slow-progressed EGFR-TKI Resistant NSCLC Apatinib（Tab. 500mg/d） combined with EGFR-TKI（as previously） - NSCLC, Apatinib | Phase 3 | Unknown | Shenzhen People's Hospital | 54 | 2017-12-01 | 2019-04-04 |
Shenzhen People's Hospital (1)
China (1)